EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

Marc E Rothenberg, Evan S Dellon, Margaret H Collins, Albert J Bredenoord, Ikuo Hirano, Kathryn A Peterson, Laura Brooks, Julie M Caldwell, Harald Fjällbrant, Hanna Grindebacke, Calvin N Ho, Matthew Keith und 5 weitere

New England Journal of Medicine · 27.06.2024 · 390 (24) · 2252-2263

DOI: 10.1056/nejmoa2313318 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 27.06.2024. Verfasst von Marc E Rothenberg und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Depar…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Eosinophilic Esophagitis, Eosinophils. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedEosinophilic EsophagitisEosinophilsAdolescentAdultAgedChildFemaleHumansMaleMiddle AgedYoung AdultDeglutition DisordersDouble-Blind MethodInterleukin-5 Receptor alpha SubunitLeukocyte Count

Substanzen

Antibodies, Monoclonal, HumanizedbenralizumabInterleukin-5 Receptor alpha Subunit

Autor:innen und Institutionen

  • From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cin…

Förderung

  • AstraZeneca

Zitieren

APA

Rothenberg, M. E., Dellon, E. S., Collins, M. H., Bredenoord, A. J., Hirano, I., Peterson, K. A., Brooks, L., Caldwell, J. M., Fjällbrant, H., Grindebacke, H., Ho, C. N., Keith, M., McCrae, C., Sinibaldi, D., White, W. I., Datto, C. J., & MESSINA Trial Investigators (2024). Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. New England Journal of Medicine, 390(24), 2252-2263. https://doi.org/10.1056/nejmoa2313318

Vancouver

Rothenberg ME, Dellon ES, Collins MH, Bredenoord AJ, Hirano I, Peterson KA, et al. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. New England Journal of Medicine. 2024;390(24):2252-2263. doi:10.1056/nejmoa2313318

BibTeX
@article{Rothenberg2024,
  author = {Rothenberg, Marc E and Dellon, Evan S and Collins, Margaret H and Bredenoord, Albert J and Hirano, Ikuo and Peterson, Kathryn A and Brooks, Laura and Caldwell, Julie M and Fjällbrant, Harald and Grindebacke, Hanna and Ho, Calvin N and Keith, Matthew and McCrae, Christopher and Sinibaldi, Dominic and White, Wendy I and Datto, Catherine J and MESSINA Trial Investigators, MESSINA Trial Investigators},
  title = {Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {24},
  pages = {2252--2263},
  doi = {10.1056/nejmoa2313318}
}
Kostenlos starten →